Harvest Fund Management’s Novo Nordisk NVO Stock Holding History

Harvest Fund Management’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-7,223	Closed	-$368K	–	579
2025 Q4	$368K	Buy	+7,223	New	+$369K	0.01%	287
2025 Q1	–	Sell	-144	Closed	-$12K	–	779
2024 Q4	$12K	Sell	144 -531	-79%	-$57.4K	﹤0.01%	659
2024 Q3	$80K	Sell	675 -20,128	-97%	-$2.68M	﹤0.01%	426
2024 Q2	$2.97M	Buy	20,803 +1,825	+10%	+$242K	0.21%	72
2024 Q1	$2.44M	Buy	18,978 +13,352	+237%	+$1.59M	0.22%	81
2023 Q4	$582K	Buy	5,626 +3,120	+125%	+$309K	0.09%	103
2023 Q3	$228K	Buy	2,506 +2,234	+821%	+$197K	0.04%	202
2023 Q2	$22K	Hold	272	–	–	﹤0.01%	494
2023 Q1	$22K	Hold	272	–	–	﹤0.01%	570
2022 Q4	$18K	Buy	272 +214	+369%	+$12.5K	﹤0.01%	605
2022 Q3	$3K	Buy	+58	New	+$3.11K	﹤0.01%	748

Other funds holding NVO

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Harvest Fund Management's NVO Position: Q1 2026 in Review

Harvest Fund Management sold out of Novo Nordisk (NVO) in Q1 2026, closing a stake of 7,223 shares — an estimated $368K sold.

Harvest Fund Management first reported a position in NVO in Q3 2022 and held it in 11 quarters. The position peaked at $2.97M in Q2 2024. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

Harvest Fund Management reported no remaining Novo Nordisk position as of Q1 2026 after selling out during the quarter.
Harvest Fund Management sold 7,223 Novo Nordisk shares in Q1 2026, an estimated $368K.
Harvest Fund Management first reported a position in Novo Nordisk in Q3 2022 and held it in 11 quarters.
Harvest Fund Management's Novo Nordisk position peaked at $2.97M in Q2 2024.
1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Harvest Fund Management's 13F filing for Q1 2026, filed 14 May 2026.